Skip Navigation

JNCI Journal of the National Cancer Institute 2005 97(13):1013-1014; doi:10.1093/jnci/dji180
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Forman, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Forman, D.
Related Collections
Right arrowResponse to this Correspondence
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2005 Oxford University Press

CORRESPONDENCE

Re: The Role of Overdiagnosis and Reclassification in the Marked Increase of Esophageal Adenocarcinoma Incidence

David Forman

Affiliation of author: Centre for Epidemiology and Biostatistics, University of Leeds, Arthington House, Cookridge Hospital, Hospital Lane, Leeds, UK

Correspondence to: David Forman, PhD, Professor of Cancer Epidemiology, University of Leeds, Centre for Epidemiology and Biostatistics, Arthington House, Cookridge Hospital, Hospital Lane, Leeds, LS16 6QB, UK (e-mail: d.forman@leeds.ac.uk).

The first 10% of the full text of this article appears below.

Pohl and Welch consider whether the reported dramatic increase in esophageal adenocarcinoma represents a real increase in disease burden or whether it can be explained by artifacts introduced by classification problems and/or increased diagnostic intensity (1). Based on an analysis of the National Cancer Institute's Surveillance, Epidemiology and End Results (SEER) database, they conclude that the observed increase not only represents a true increase in . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Response to this Correspondence

RESPONSE: Re: The Role of Overdiagnosis and Reclassification in the Marked Increase of Esophageal Adenocarcinoma Incidence
Heiko Pohl and H. Gilbert Welch
J Natl Cancer Inst 2005 97: 1014. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
A. Steffen, M. B. Schulze, T. Pischon, T. Dietrich, E. Molina, M.-D. Chirlaque, A. Barricarte, P. Amiano, J. R. Quiros, R. Tumino, et al.
Anthropometry and Esophageal Cancer Risk in the European Prospective Investigation into Cancer and Nutrition
Cancer Epidemiol. Biomarkers Prev., July 1, 2009; 18(7): 2079 - 2089.
[Abstract] [Full Text] [PDF]

Home page
 MutagenesisHome page
R. G. Sturmey, C. P. Wild, and L. J. Hardie
Removal of red light minimizes methylene blue-stimulated DNA damage in oesophageal cells: implications for chromoendoscopy
Mutagenesis, May 1, 2009; 24(3): 253 - 258.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
P. J. Kahrilas
Gastroesophageal Reflux Disease
N. Engl. J. Med., October 16, 2008; 359(16): 1700 - 1707.
[Full Text] [PDF]